As of 2024-12-14, the Intrinsic Value of Atea Pharmaceuticals Inc (AVIR) is
-51.51 USD. This Atea valuation is based on the model Peter Lynch Fair Value.
With the current market price of 2.95 USD, the upside of Atea Pharmaceuticals Inc is
-1,845.95%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-51.51 USD
Intrinsic Value
Atea Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-51.51 - -51.51 |
-51.51 |
-1,845.95% |
| P/E |
(35.85) - (57.23) |
(50.37) |
-1807.5% |
| DDM - Stable |
(13.81) - (37.01) |
(25.41) |
-961.3% |
| DDM - Multi |
(9.78) - (20.67) |
(13.31) |
-551.2% |
Atea Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
249.16 |
| Beta |
1.57 |
| Outstanding shares (mil) |
84.46 |
| Enterprise Value (mil) |
150.69 |
| Market risk premium |
4.60% |
| Cost of Equity |
11.73% |
| Cost of Debt |
5.00% |
| WACC |
8.34% |